Table of Contents Table of Contents
Previous Page  198 / 206 Next Page
Information
Show Menu
Previous Page 198 / 206 Next Page
Page Background

147. Diagnosis of catheter-related infections / F. Blot [et al.] //

Catheter related infections. 2-nd ed. New York. - 2004. - P. 37-72.

148. Drug Actions, Interactions, Reactions. Program of the American

Academy of Dermatology / N.H. Shear [et al.] // Academy, 2000, 5.

149. Edwards, I.R. Adverse drug reactions: definitions, diagnosis, and

management / I.R.Edwards, J.K.Aronson // The Lancet. - 2000. - Vol 356 . -

N7: 1255-1261.

150. Epidemiology of drug exposure and adverse drug reactions in two

swiss departments of internal medicine / K. Fattinger [et al.] // Br. J. Clin.

Pharmacol., 2000, 49(2), 158-167.

151. Epidemiology of drug exposure and adverse drug reactions in two

swiss departments of internal medicine / K. Fattinger [et al.] // Br. J. Clin.

Pharmacol., 2000, 49(2), 158-167.

152. Fletcher, A.P. Spontaneous adverse drug reaction reporting vs.

event reporting vs. event monitoring: a comparison / A.P. Fletcher // J. Roy.

Soc. Med., 1991, 84, 341-344.

153. Gualeri,

E.

Катетеризация

подключичной

вены:

ультразвуковой контроль позволяет менее опытным врачам добиться

лучших результатов / E. Gualeri, S.A. Deppe, M.E. Sipperly // Вестник

интенсивной терапии, 2006. - №4. - С. 77-81.

154. Haig, K. One Hospital’s Journey Toward Patient Safety,

Medscape Money & Medicine, 2003, 4(2).

155. Immunological principles of adverse drug reactions: the initiation

and propagation of immune responses elicited by drug treatment / D.J. Naisbitt

[et al.] // Drug. Saf. 2000, 23(6), 483-507.

156. Incidence of adverse drug events and potential adverse drug

events. Implications for prevention / D.W. Bates [et al.] // JAMA, 1995, 274,

29-34.

157. Incidence of adverse drug events and potential adverse drug

194